Prudential Financial
IPSC icon

Prudential Financial’s Century Therapeutics IPSC Stock Holding History

Prudential Financial’s Portfolio IPSC Stock Details IPSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$57.2K Sell
25,300
-34,500
-58% -$72.5K ﹤0.01% 2298
2025
Q4 		$59.5K Hold
59,800
– – ﹤0.01% 2139
2025
Q3 		$29.8K Buy
59,800
+14,400
+32% +$7.76K ﹤0.01% 2385
2025
Q2 		$25.4K Buy
+45,400
New +$24.4K ﹤0.01% 2386
2025
Q1 		– Sell
-15,150
Closed -$15.3K – 2331
2024
Q4 		$15.3K Hold
15,150
– – ﹤0.01% 2277
2024
Q3 		$25.9K Hold
15,150
– – ﹤0.01% 2684
2024
Q2 		$38.6K Buy
15,150
+3,330
+28% +$10.5K ﹤0.01% 2639
2024
Q1 		$49.4K Buy
+11,820
New +$50K ﹤0.01% 2591

Other funds holding IPSC

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Prudential Financial's IPSC Position: Q1 2026 in Review

Prudential Financial reduced its Century Therapeutics (IPSC) stake by 58% in Q1 2026, selling an estimated $72.5K and leaving 25,300 shares worth $57.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2298.

Prudential Financial first reported a position in IPSC in Q1 2024 and has held it in 8 quarters since. The position peaked at $59.5K in Q4 2025. 72 funds tracked by Wall St. Rank hold IPSC as of Q1 2026.

  • Prudential Financial held 25,300 shares of Century Therapeutics worth $57.2K as of Q1 2026.
  • Prudential Financial sold 34,500 Century Therapeutics shares in Q1 2026, an estimated $72.5K.
  • Century Therapeutics made up ﹤0.01% of Prudential Financial's portfolio in Q1 2026, its #2298 holding.
  • Prudential Financial first reported a position in Century Therapeutics in Q1 2024 and has held it in 8 quarters since.
  • Prudential Financial's Century Therapeutics position peaked at $59.5K in Q4 2025.
  • 72 funds tracked by Wall St. Rank held Century Therapeutics as of Q1 2026.

Based on Prudential Financial's 13F filing for Q1 2026, filed 13 May 2026.